BioCatalystWatch
BDRXWorkspace / BDRX / OverviewCompany library
Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals Plc (BDRX)

Website

Price
Market cap
Next catalystDec 10, 2026MTX240 · Regulatory meetingCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

eRapa

mTOR

PreINDP1P2P3FilingApproved
Upcoming / outlook

eRapa

mTOR

PreINDP1P2P3FilingApproved
Upcoming / outlook

MTX240

PDE3A × SLFN12

PreINDP2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

eRapa

mTOR

PreINDP1P2P3FilingApproved
Upcoming / outlook

eRapa

mTOR

PreINDP1P2P3FilingApproved
Upcoming / outlook

MTX240

PDE3A × SLFN12

PreINDP2P3FilingApproved
Upcoming / outlook

Other pipelines

MTX240

PDE3A × SLFN12

PreINDP2P3FilingApproved
Upcoming / outlook

MTD217

PreINDP1P2P3FilingApproved

History / paused

eRapa

mTOR

PreINDP1P2P3FilingApproved

Lyn kinase

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

BDRX PR & News

PR & News

BDRX SEC archive